1-Decyl-3-((S)-1-methyl-pyrrolidin-2-yl)-pyridinium iodide

ID: ALA56296

PubChem CID: 10025698

Max Phase: Preclinical

Molecular Formula: C20H35IN2

Molecular Weight: 303.51

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCC[n+]1cccc([C@@H]2CCCN2C)c1.[I-]

Standard InChI:  InChI=1S/C20H35N2.HI/c1-3-4-5-6-7-8-9-10-16-22-17-11-13-19(18-22)20-14-12-15-21(20)2;/h11,13,17-18,20H,3-10,12,14-16H2,1-2H3;1H/q+1;/p-1/t20-;/m0./s1

Standard InChI Key:  FCNGVUOMLWKVEV-BDQAORGHSA-M

Molfile:  

     RDKit          2D

 23 23  0  0  0  0  0  0  0  0999 V2000
    1.5792   -1.6792    0.0000 I   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7333   -0.7125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0125    0.5333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4125    0.5333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3000    0.9458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0125   -0.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4458   -0.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7333   -1.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0250    1.0833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7333    0.9458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4042   -0.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1250    1.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4458    0.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6917    1.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0208   -1.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1125   -6.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1167   -5.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3083   -3.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3083   -4.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4042   -4.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4042   -5.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0208   -2.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8292   -6.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  6  1  0
  4  5  1  0
  5  3  1  6
  6  2  2  0
  7  2  1  0
  8  2  1  0
  9  4  1  0
 10 13  1  0
 11  4  1  0
 12  5  1  0
 13  7  2  0
 14 12  1  0
 15  8  1  0
 16 17  1  0
 17 21  1  0
 18 22  1  0
 19 18  1  0
 20 19  1  0
 21 20  1  0
 22 15  1  0
 23 16  1  0
  3 10  2  0
  9 14  1  0
M  CHG  2   1  -1   2   1
M  END

Associated Targets(Human)

CHRNB2 Tclin Neuronal acetylcholine receptor; alpha4/beta2 (3972 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chrna4 Neuronal acetylcholine receptor; alpha4/beta2 (3557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna7 Neuronal acetylcholine receptor protein alpha-7 subunit (3047 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a8 Creatine transporter (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrnb3 Neuronal acetylcholine receptor subunit alpha-6/beta-3 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 303.51Molecular Weight (Monoisotopic): 303.2795AlogP: 4.88#Rotatable Bonds: 10
Polar Surface Area: 7.12Molecular Species: NEUTRALHBA: 1HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.64CX LogP: 1.21CX LogD: 0.77
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.44Np Likeness Score: 0.31

References

1. Crooks PA, Ayers JT, Xu R, Sumithran SP, Grinevich VP, Wilkins LH, Deaciuc AG, Allen DD, Dwoskin LP..  (2004)  Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.,  14  (8): [PMID:15050618] [10.1016/j.bmcl.2003.10.074]
2. Ayers JT, Dwoskin LP, Deaciuc AG, Grinevich VP, Zhu J, Crooks PA..  (2002)  bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors.,  12  (21): [PMID:12372503] [10.1016/s0960-894x(02)00687-x]
3. Matera C, Pucci L, Fiorentini C, Fucile S, Missale C, Grazioso G, Clementi F, Zoli M, De Amici M, Gotti C, Dallanoce C..  (2015)  Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization.,  101  [PMID:26164842] [10.1016/j.ejmech.2015.06.039]

Source